Ernexa Therapeutics Inc. Interest Expense, Other
Ernexa Therapeutics Inc. (ERNA) reported Interest Expense, Other of $138.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2021-03-11
- Ernexa Therapeutics Inc. interest expense, other for fiscal 2020 was $138.00K, a 44.58% decline from fiscal 2019.
- Ernexa Therapeutics Inc. interest expense, other for fiscal 2019 was $249.00K, a 35.99% decline from fiscal 2018.
- Ernexa Therapeutics Inc. interest expense, other for fiscal 2018 was $389.00K, a 21.89% decline from fiscal 2017.
- Ernexa Therapeutics Inc. interest expense, other for fiscal 2017 was $498.00K, a 13.54% decline from fiscal 2016.
| Period end | Interest Expense, Other 12 month |
|---|---|
| 2020-12-31 | $138.00K 10-K · filed 2021-03-11 |
| 2019-12-31 | $249.00K 10-K · filed 2021-03-11 |
| 2018-12-31 | $389.00K 10-K · filed 2020-03-19 |
| 2017-12-31 | $498.00K 10-K · filed 2019-03-22 |
| 2016-12-31 | $576.00K 10-K · filed 2018-03-09 |
| 2015-12-31 | $484.00K 10-K · filed 2017-03-09 |
| 2014-12-31 | $223.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |